Function: Blocks cleavage of complement component C5, inhibiting downstream pro-inflammatory effects (C5a anaphylatoxin and MAC formation) .
Species Specificity: Effective in mice only; no cross-reactivity with human C5 .
Binding Affinity:
Applications: Validated in arthritis, renal injury, and neurodegenerative models .
Clinical Use:
Term Clarification: Verify if "CB5-A" refers to a proprietary or developmental antibody not yet published.
Alternative Targets: Explore antibodies targeting C5 (complement) or CD5 (lymphocyte marker), which share functional or structural similarities.
Experimental Validation: If CB5-A is a novel antibody, provide sequence data, epitope mapping, and in vitro neutralization assays to establish its profile.